Temsirolimus 25 mg/ml, 100 mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 25 mg/ml, 100 mg

Reference Brands: Torisel (USA)

Category: Oncology Cancer Care

Temsirolimus is a Oncology Cancer Care product available as Injection in strengths 25 mg/ml, 100 mg. It corresponds to the reference brand Torisel (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Temsirolimus is an intravenous anticancer medication sold under the brand name Torisel and is primarily used for the treatment of advanced renal cell carcinoma (RCC). It is a derivative and prodrug of sirolimus and works by inhibiting the mammalian target of rapamycin (mTOR), a key protein kinase that regulates cell growth, proliferation, metabolism, and angiogenesis. By blocking mTOR signaling, temsirolimus slows the growth and division of cancer cells and helps reduce tumor progression.

Developed by Wyeth Pharmaceuticals, temsirolimus was approved by the U.S. Food and Drug Administration (FDA) in May 2007 and by the European Medicines Agency (EMA) in November 2007. It is administered intravenously under medical supervision, typically in patients with advanced or poor-risk RCC. Temsirolimus provides a targeted therapeutic option for patients who may not be suitable for surgical interventions, offering a mechanism-based approach to controlling tumor growth.